Literature DB >> 7515927

Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome.

N V Henriquez1, G T Rijkers, B J Zegers.   

Abstract

The X-linked immunodeficiency Wiskott-Aldrich syndrome (WAS) is a condition that includes a deficient anti-polysaccharide Ab response. Recently, it has been suggested that B cells from patients with WAS show a defective calcium mobilization response upon engagement of sIgM. Because primarily EBV-transformed cells were used in these studies, we tested freshly isolated blood B cells for their calcium mobilization capability upon engagement of sIg and CD19. No significant differences in the calcium mobilization capability of CD20+ B cells of four individual WAS patients compared with capability in normal controls were found. Receptor desensitization as assessed by calcium mobilization inhibition also seemed to be intact. T cells were tested for their anti-CD3-induced calcium flux and, again, no abnormalities could be observed when compared with T cells from healthy individuals. We conclude that WAS B and T cells can be stimulated into a normal calcium mobilization response when their AgRs are cross-linked. It is highly improbable that the immune dysfunction observed in WAS patients is related to a direct disorder of their B and/or T cell AgRs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515927

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome.

Authors:  J Y Park; A Shcherbina; F S Rosen; A P Prodeus; E Remold-O'Donnell
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma.

Authors:  Marco Catucci; Maria Carmina Castiello; Francesca Pala; Marita Bosticardo; Anna Villa
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

3.  Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.

Authors:  Philipp A Lang; Namir Shaabani; Stephanie Borkens; Nadine Honke; Stefanie Scheu; Sarah Booth; Dirk Brenner; Andreas Meryk; Carmen Barthuber; Mike Recher; Tak W Mak; Pamela S Ohashi; Dieter Häussinger; Gillian M Griffiths; Adrian J Thrasher; Gerben Bouma; Karl S Lang
Journal:  J Allergy Clin Immunol       Date:  2012-11-06       Impact factor: 10.793

Review 4.  Actin cytoskeletal defects in immunodeficiency.

Authors:  Dale A Moulding; Julien Record; Dessislava Malinova; Adrian J Thrasher
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

Review 5.  Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation.

Authors:  Gerben Bouma; Siobhan O Burns; Adrian J Thrasher
Journal:  Immunobiology       Date:  2009-07-22       Impact factor: 3.144

6.  Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis.

Authors:  Almut Meyer-Bahlburg; Shirly Becker-Herman; Stephanie Humblet-Baron; Socheath Khim; Michele Weber; Gerben Bouma; Adrian J Thrasher; Facundo D Batista; David J Rawlings
Journal:  Blood       Date:  2008-08-07       Impact factor: 22.113

7.  Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.

Authors:  Maria Carmina Castiello; Marita Bosticardo; Francesca Pala; Marco Catucci; Nicolas Chamberlain; Menno C van Zelm; Gertjan J Driessen; Malgorzata Pac; Ewa Bernatowska; Samantha Scaramuzza; Alessandro Aiuti; Aisha V Sauer; Elisabetta Traggiai; Eric Meffre; Anna Villa; Mirjam van der Burg
Journal:  J Autoimmun       Date:  2013-12-25       Impact factor: 7.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.